DKNDKN
D

DKN

Developing AI-powered drug discovery and development solutions.

2023Inactive

About

DKN is a startup focused on developing AI-powered solutions for drug discovery and development. They leverage AI to accelerate the identification of drug candidates and optimize the development process.

Technology stack

detected 2026-05-27
Est. monthly stack spend~$70/mo
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does DKN do?

DKN is a startup focused on developing AI-powered solutions for drug discovery and development. They leverage AI to accelerate the identification of drug candidates and optimize the development process.

How much funding has DKN raised?

DKN has raised a total of $20M in funding. The most recent round on record is Seed.

Where is DKN headquartered?

DKN is headquartered in Tel Aviv, Israel.

When was DKN founded?

DKN was founded in 2023.

What industry does DKN operate in?

DKN operates in Biotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals, Biotech, AI-Driven Drug Discovery.

What is DKN's current status?

DKN's current operating status is: Inactive.